CINECA IRIS Institutional Research Information System

MARCOCCI, CLAUDIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 30.348
AS - Asia 14.321
EU - Europa 10.609
SA - Sud America 2.511
AF - Africa 702
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 16
Totale 58.532
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 29.529
SG - Singapore 4.398
CN - Cina 4.016
IT - Italia 3.115
HK - Hong Kong 2.808
BR - Brasile 2.124
SE - Svezia 2.056
DE - Germania 1.096
BG - Bulgaria 1.051
VN - Vietnam 982
GB - Regno Unito 646
TR - Turchia 640
CA - Canada 622
RU - Federazione Russa 522
UA - Ucraina 468
FI - Finlandia 463
KR - Corea 384
AT - Austria 377
IN - India 292
CI - Costa d'Avorio 273
FR - Francia 261
CH - Svizzera 169
AR - Argentina 131
SN - Senegal 124
JP - Giappone 122
BD - Bangladesh 114
MX - Messico 85
ZA - Sudafrica 85
IQ - Iraq 84
ID - Indonesia 74
EC - Ecuador 73
SA - Arabia Saudita 68
NL - Olanda 66
PL - Polonia 57
BE - Belgio 55
UZ - Uzbekistan 55
MA - Marocco 50
CO - Colombia 46
PK - Pakistan 44
ES - Italia 43
VE - Venezuela 43
NG - Nigeria 42
EG - Egitto 37
PY - Paraguay 29
JO - Giordania 25
KE - Kenya 25
CZ - Repubblica Ceca 24
AU - Australia 21
DZ - Algeria 21
NP - Nepal 21
IE - Irlanda 20
CL - Cile 19
IL - Israele 17
UY - Uruguay 17
AZ - Azerbaigian 16
DO - Repubblica Dominicana 16
JM - Giamaica 16
AE - Emirati Arabi Uniti 15
PE - Perù 15
PH - Filippine 15
RO - Romania 15
LB - Libano 14
MY - Malesia 14
CR - Costa Rica 12
EU - Europa 12
GR - Grecia 12
LT - Lituania 12
PS - Palestinian Territory 12
AL - Albania 11
BB - Barbados 11
OM - Oman 11
TT - Trinidad e Tobago 11
BO - Bolivia 10
HU - Ungheria 10
KG - Kirghizistan 10
KZ - Kazakistan 10
IR - Iran 9
BJ - Benin 8
DK - Danimarca 8
ET - Etiopia 8
LV - Lettonia 8
NI - Nicaragua 8
PA - Panama 8
PT - Portogallo 8
TN - Tunisia 8
BS - Bahamas 7
HN - Honduras 7
RS - Serbia 7
KW - Kuwait 6
TW - Taiwan 6
BH - Bahrain 5
GE - Georgia 5
SK - Slovacchia (Repubblica Slovacca) 5
EE - Estonia 4
GY - Guiana 4
HR - Croazia 4
LA - Repubblica Popolare Democratica del Laos 4
NZ - Nuova Zelanda 4
AM - Armenia 3
BA - Bosnia-Erzegovina 3
Totale 58.456
Salva come PNG Salva come JPEG
Città #
Woodbridge 3.471
Ashburn 3.051
Hong Kong 2.777
Fairfield 2.769
Singapore 2.301
Houston 2.108
Ann Arbor 2.069
Chandler 1.739
Dallas 1.680
Santa Clara 1.451
Seattle 1.160
Sofia 1.050
Wilmington 996
Shanghai 977
Cambridge 925
Beijing 864
Milan 847
New York 744
Jacksonville 539
Ottawa 516
Boardman 512
Serra 510
Hefei 497
Princeton 462
Lawrence 432
Los Angeles 401
Medford 392
Seoul 371
Vienna 330
Nanjing 293
Izmir 280
Abidjan 273
Des Moines 263
Munich 246
Istanbul 242
Florence 222
Ho Chi Minh City 212
Dearborn 208
Dong Ket 205
London 165
São Paulo 162
San Diego 156
Redondo Beach 155
Bern 153
Buffalo 150
Frankfurt am Main 132
Hanoi 126
Dakar 122
Nanchang 120
Jüchen 113
Pisa 109
Tokyo 105
Bremen 97
Rome 93
Redwood City 84
Lancaster 83
Ogden 80
Helsinki 74
Düsseldorf 70
Kunming 69
Rio de Janeiro 69
Marseille 64
Turku 64
Boulder 63
Hebei 61
Shenyang 61
Chicago 57
Columbus 57
The Dalles 57
Changsha 56
Brussels 53
Norwalk 52
Tashkent 51
Belo Horizonte 47
Kocaeli 46
Washington 46
Fuzhou 45
Tianjin 45
Piscataway 43
Guangzhou 41
Council Bluffs 39
Baghdad 38
Falls Church 38
Brooklyn 37
Jiaxing 37
San Francisco 37
Hyderabad 36
Johannesburg 36
Dhaka 35
Phoenix 35
Lagos 34
Nuremberg 34
San Jose 33
Kent 31
Denver 30
Toronto 30
Brasília 29
Warsaw 29
Campinas 28
Curitiba 28
Totale 42.555
Salva come PNG Salva come JPEG
Nome #
Complicanze chirurgiche in pazienti sottoposti a decompressione orbitaria per oftalmopatia di Graves [Surgical complications in orbital decompression for Graves’ orbitopathy] 430
Thyroid directed antibodies 355
Natural history of graves’ orbitopathy after treatment 253
Antioxidant Actions of Selenium in Orbital Fibroblasts: A Basis for the Effects of Selenium in Graves' Orbitopathy 225
Neuropsychological assessment in schoolchildren from an area of moderate iodine deficiency 217
Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial 215
Orbital cobalt irradiation combined with systemic corticosteroids for Graves' ophthalmopathy: comparison with systemic corticosteroids alone 213
A quick intraoperative parathyroid hormone assay in the surgical management of patients with primary hyperparathyroidism: a study of 206 consecutive cases 213
Clinical profile of juvenile primary hyperparathyroidism: a prospective study 211
Action of three bioavailable antioxidants in orbital fibroblasts from patients with Graves’ orbitopathy (GO): a new frontier for GO treatment? 210
Role of the underlying thyroid disease on the phenotype of graves' orbitopathy in a tertiary referral center 204
1,25-dihydroxyvitamin D3 specifically binds to a human breast cancer cell line (T47D) and stimulates growth 203
Sortilin is a putative post-endocytic receptor of thyroglobulin 202
Primary hyperparathyroidism 202
Parathyroid Carcinoma and Adenoma Co-existing in One Patient: Case Report and Comparative Proteomic Analysis 202
A reappraisal of the Rb1 gene abnormalities in the diagnosis of parathyroid cancer 200
Use of low-dose radioiodine ablation for Graves' orbitopathy: results of a pilot, perspective study in a small series of patients 199
Recent advances in the understanding of humoral and cellular mechanisms implicated in thyroid autoimmune disorders. 198
First evidence of TRPV5 and TRPV6 channels in human parathyroid glands: possible involvement in neoplastic transformation. 196
Management of thyrotoxicosis induced by PD1 or PD-L1 blockade 194
Norepinephrine and thyrotropin stimulation of iodide efflux in FRTL-5 thyroid cells involves metabolites of arachidonic acid and is associated with the iodination of thyroglobulin 193
Sex hormone-binding globulin measurement in patients with inappropriate secretion of thyrotropin (IST): evidence against selective pituitary thyroid hormone resistance in nonneoplastic IST 193
Cytolytic T cells with Th1-like cytokine profile predominate in retroorbital lymphocytic infiltrates of Graves' ophthalmopathy 191
A 70-year-old woman with Bilateral Orbital Infiltrative disease. 191
More on smoking habits and Graves' ophthalmopathy 190
Morphometric vertebral fractures in postmenopausal women with primary hyperparathyroidism 190
TSH-Dependent Expression of the LDL Receptor-Associated Protein (RAP) in Thyroid Epithelial Cells 190
A proteomic approach to study parathyroid glands 190
Prognostic factors for pancreatic neuroendocrine neoplasms (pNET) and the risk of small non-functioning pNET 190
Autoantibodies against type I interferons as an additional diagnostic criterion for autoimmune polyendocrine syndrome type I 189
Beta-catenin activation is not involved in sporadic parathyroid carcinomas and adenomas 189
High Serum Cholesterol Is a Novel Risk Factor for Graves' Orbitopathy: Results of a Cross-Sectional Study 189
Sodium/proton exchange in the maintenance of intracellular pH in FRTL-5 thyroid cells 188
Characterization of monoclonal thyroid-stimulating and thyrotropin binding-inhibiting autoantibodies from a Hashimoto's patient whose children had intrauterine and neonatal thyroid disease 188
A new mutation of the MEN1 gene in an italian kindred with multiple endocrine neoplasia type 1 188
Evaluation of formalin-fixed paraffin-embedded tissues in the proteomic analysis of parathyroid glands. 187
Association of the changes in cytosolic Ca2+ and iodide efflux induced by thyrotropin and by the stimulation of alpha 1-adrenergic receptors in cultured rat thyroid cells 185
Cinacalcet efficacy in patients with moderately severe primary hyperparathyroidism according to the European Medicine Agency prescription labeling. 185
Effect of actinomycin D on iodide transport in FRTL-5 thyroid cells 184
Enalapril reduces proliferation and hyaluronic acid release in orbital fibroblasts 184
TSH-Dependent expression of the LDL receptor-associated protein (RAP) in thyroid epithelial cells 183
The presence of anti-thyroglobulin (TgAb) and/or anti-thyroperoxidase antibodies (TPOAb) does not exclude the diagnosis of type 2 amiodarone-induced thyrotoxicosis 181
Acute and severe liver damage associated with intravenous glucocorticoid pulse therapy in patients with graves’ ophthalmopathy 180
Active Surveillance In Papillary Thyroid Microcarcinomas (PMCS): A 2 Years Follow Up (FU) At A Single Center 179
Six novel MEN1 gene mutations in sporadic parathyroid tumors 179
Agretti P, De Marco G, De Servi M, Marcocci C, Vitti P, Pinchera A, Tonacchera M.: Evidence for protein and mRNA TSHr expression in fibroblasts from patients with thyroid-associated ophthalmopathy (TAO) after adipocytic differentiation 178
A patient with MEN1 and end‑stage chronic kidney disease due to Alport syndrome: Decision making on the eligibility of transplantation 178
Simultaneous assay of thyroid adenylate cyclase- and growth-stimulating antibodies using FRTL-5 cells. Evidence suggesting their identity in patients with Graves' disease. 177
Outcome of Graves' Orbitopathy after Total Thyroid Ablation and Glucocorticoid Treatment: Follow-Up of a Randomized Clinical Trial 176
Effects of selenium on short-term control of hyperthyroidism due to Graves' disease treated with methimazole: results of a randomized clinical trial 176
Hereditary hypercalcemia caused by a homozygous pathogenic variant in the cyp24a1 gene: A case report and review of the literature 176
Calcium-sensing receptor gene polymorphism is not associated with bone mineral density in Italian postmenopausal women 175
Spontaneous improvement of untreated mild graves' ophthalmopathy: Rundle's curve revisited. 173
Comparison Between Total Thyroidectomy and Medical Therapy for Amiodarone-Induced Thyrotoxicosis 173
Different somatic alterations of the HRPT2 gene in a patient with recurrent sporadic primary hyperparathyroidism carrying an HRPT2 germline mutation 173
Graves' Disease Induced by Immune Checkpoint Inhibitors: A case report and Review of the literature 173
Prognostic factors for pancreatic neuroendocrine neoplasms (pNET) and the risk of small non-functioning pNET 172
Relationship between serum cholesterol and Graves’ orbitopathy (GO): a confirmatory study 172
Diabetes insipidus is an unfavorable prognostic factor for response to glucocorticoids in patients with autoimmune hypophysitis 171
Antioxidant effects of β-carotene, but not of retinol and vitamin E, in orbital fibroblasts from patients with Graves' orbitopathy (GO) 171
Demonstration and organ distribution of the 1,25-dihydroxyvitamin D3-binding protein in fish (A. anguilla) 170
Graves' orbitopathy as a rare disease in Europe: a European Group on Graves' Orbitopathy (EUGOGO) position statement 169
Calcium-sensing receptor gene polymorphisms in primary hyperparathyroidism 168
THERAPEUTIC CONTROVERSIES. RADIOIODINE MAY BE BAD FOR GRAVES’ OPHTHALMOPATHY , BUT…… 167
Hypovitaminosis D in patients with heart failure: effects on functional capacity and patients' survival 167
Do clinical manifestations of resistance to thyroid hormone correlate with the functional alteration of the corresponding mutant thyroid hormone-beta receptors? 166
Measurement of 1,25-dihydroxyvitamin D3 receptors in breast cancer and their relationship to biochemical and clinical indices 165
Chirurgia dello strabismo nella oftalmopatia endocrina. 165
Cytokine antagonists: new ideas for the management of Graves' ophthalmopathy 165
VARIABLES AFFECTING THE LONG TERM OUTCOME OF GRAVES' ORBITOPATHY FOLLOWING HIGH DOSE INTRAVENOUS GLUCOCORTICOID PULSE THERAPY IN PATIENTS NOT TREATED WITH ORBITAL RADIOTHERAPY 165
Occurrence of Graves’ Orbitopathy and of Graves’ hyperthyroidism after a trauma to the eye 165
Role of thyroglobulin in the pathogenesis of Graves’ ophthalmopathy: the hypothesis of Kriss revisited 164
No evidence for mutations in the calcium-sensing receptor gene in sporadic parathyroid adenomas 164
Familial hypocalciuric hypercalcemia type 1 due to a novel homozygous mutation of the calcium-sensing receptor gene 163
Thyroid imaging in the management of anti-PD1/PD-L1 induced thyrotoxicosis 163
Studies on the occurrence of ophthalmopathy in Graves' disease 162
Impaired Thyroglobulin (Tg) Secretion By FRTL-5 Cells Transfected With Soluble Receptor Associated Protein (RAP): Evidence For A Role Of RAP In The Tg Biosynthetic Pathway 162
Autoimmune hepatitis during intravenous glucocorticoid pulse therapy for Graves' ophthalmopathy treated successfully with glucocorticoids themselves 162
A novel germline mutation in the aryl hydrocarbon receptor-interacting protein (Aip) gene in an Italian family with gigantism 162
Optic neuropathy in 2 thyroidectomized patients with moderate to severe Graves’ ophthalmopathy following L-thyroxine withdrawal prior to radioiodine treatment for thyroid carcinoma 162
a novel germline mutation of men 1 gene in a patient with acromegaly and multiple endocrine tumors 161
Usefulness of echo-color Doppler in differentiating parathyroid lesions from other cervical masses 161
Consensus statement of the European Group on Graves' Orbitopathy (EUGOGO) on management of Graves' Orbitopathy 161
Statins for Graves' orbitopathy (STAGO): a phase 2, open-label, adaptive, single centre, randomised clinical trial 161
The PRIMARA study: A prospective, descriptive, observational study to review cinacalcet use in patients with primary hyperparathyroidism in clinical practice 161
Orbital radiotherapy for Graves' ophthalmopathy 160
Glycosaminoglycans provide a binding site for thyroglobulin in orbital tissues of patients with thyroid-associated ophthalmopathy 160
Clinical heterogeneity of hypophysitis secondary to PD-1/PD-L1 blockade: insights from four cases 160
Genetic analysis of the MEN1 gene and HPRT2 locus in two Italian kindreds with familial isolated 159
Fatal and non-fatal adverse events of glucocorticoid therapy for Graves' orbitopathy: a questionnaire survey among members of the European Thyroid Association. 159
Parathyroid expression of calcium-sensing receptor protein and in vivo parathyroid hormone-Ca(2+) set-point in patients with primary hyperparathyroidism 159
Cross-cultural validity of the thyroid-specific quality-of-life patient-reported outcome measure, ThyPRO 159
Orbital irradiation in the treatment of Graves' ophthalmopathy 158
Whole exome sequencing in familial isolated primary hyperparathyroidism 158
Clinical presentation and management of patients with primary hyperparathyroidism in Italy 158
VITAMIN D STATUS MAY CONTRIBUTE TO SERUM IGF1 CONCENTRATIONS IN HEALTHY SUBJECTS 157
Update on parathyroid carcinoma 157
Diabetes mellitus induced by somatostatin analogue therapy is not permanent in acromegalic patients 157
Role of orbital radiotherapy in the treatment of Graves' ophthalmopathy 156
A treatment strategy for Graves' orbitopathy 156
Totale 18.306
Salva come PNG Salva come JPEG
Categoria #
all - tutte 172.342
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 172.342
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.942 0 0 0 0 0 118 198 276 287 317 244 502
2021/20224.941 80 251 119 376 919 653 124 237 324 312 274 1.272
2022/20235.791 727 746 430 433 650 770 47 453 1.058 29 387 61
2023/20243.935 494 415 545 219 561 708 163 138 54 28 197 413
2024/202513.330 66 502 188 698 1.211 1.155 1.077 766 1.400 1.781 1.500 2.986
2025/20269.764 1.107 2.109 2.181 1.735 1.386 1.246 0 0 0 0 0 0
Totale 59.213